Need Regulatory Help? Try Our Platform
Post your regulatory questions or request quotations from verified pharmaceutical consultants worldwide. Get matched with experts who specialize in your market.
January 5, 2026
Approximately 5 minutes
Exemptions from Medical Device Notification in New Zealand
Exemptions from Medical Device Notification in New Zealand
1. Legal Basis and Purpose
Under section 4 of the Medicines (Database for Medical Devices) Regulations 2005, certain medical devices are exempt from the requirement to notify details to the Web Assisted Notification of Devices (WAND) database before supply in New Zealand. These exemptions apply to low-risk or specific-use devices where full notification is not considered necessary to protect public health, while general obligations under the Medicines Act 1981 (e.g., safety, quality, and performance) still apply. Source: https://www.medsafe.govt.nz/regulatory/DevicesNew/3-8MDExempt.asp
The exemptions aim to reduce regulatory burden for minimal-risk products without compromising safety. Sponsors must ensure exempted devices comply with essential principles of safety and performance, labelling requirements, and post-market vigilance obligations. Source: https://www.medsafe.govt.nz/regulatory/DevicesNew/3-8MDExempt.asp
2. Categories of Exempt Devices
The regulations provide exemptions in the following main categories:
-
Custom-made devices: Devices specifically made for a named patient or healthcare professional based on their written prescription or order, intended for the sole use of that individual. These must not be mass-produced and are exempt from WAND notification. Source: https://www.medsafe.govt.nz/regulatory/DevicesNew/3-8MDExempt.asp
-
Devices for clinical investigation/performance evaluation: Devices intended solely for use in clinical investigations or performance evaluation studies, provided they are not placed on the market for general supply and meet specific conditions (e.g., ethics approval where required). Source: https://www.medsafe.govt.nz/regulatory/DevicesNew/3-8MDExempt.asp
-
Low-risk devices supplied in limited circumstances: Certain Class I non-IVD devices or Class 1 IVD devices that are supplied in small quantities or for specific purposes may qualify for exemption if they meet defined criteria (e.g., not intended for widespread distribution). Source: https://www.medsafe.govt.nz/regulatory/DevicesNew/3-8MDExempt.asp
-
Other specific exemptions: Include devices supplied solely for export, devices used only within a healthcare facility for in-house purposes without commercial supply, and certain heritage or antique devices not intended for clinical use. Source: https://www.medsafe.govt.nz/regulatory/DevicesNew/3-8MDExempt.asp
3. Conditions and Responsibilities for Exempt Devices
Even when exempt from WAND notification, sponsors/manufacturers must:
- Ensure the device complies with the essential principles of safety and performance.
- Provide appropriate labelling and instructions for use in English.
- Maintain records of design, manufacture, and distribution.
- Report adverse events, field safety corrective actions, and cooperate with Medsafe investigations.
- Not make prohibited therapeutic claims in advertising or promotion.
Custom-made devices must be accompanied by a written statement from the manufacturer confirming compliance with essential principles and detailing the custom nature of the device. Source: https://www.medsafe.govt.nz/regulatory/DevicesNew/3-8MDExempt.asp
4. Borderline Cases and Advice
For devices that may fall on the border of exemption (e.g., limited production runs or devices modified for specific patients), sponsors are advised to contact Medsafe for clarification before supply. Misclassification or inappropriate reliance on exemptions can result in enforcement action. Source: https://www.medsafe.govt.nz/regulatory/DevicesNew/3-8MDExempt.asp
5. Additional Notes
The exemptions do not apply to devices that are otherwise classified as higher risk or intended for general commercial supply. Medsafe maintains oversight through post-market surveillance, and sponsors remain liable for any safety issues. The guidance aligns with international practices for low-risk/custom devices while ensuring public health protection. Source: https://www.medsafe.govt.nz/regulatory/DevicesNew/3-8MDExempt.asp
This framework balances regulatory oversight with practical access to specialized or minimal-risk medical devices in New Zealand. Source: https://www.medsafe.govt.nz/regulatory/DevicesNew/3-8MDExempt.asp
Ask Anything
We'll follow up with you personally.
Related Articles
Approximately 5 minutes
Definition of Medical Device under New Zealand's Medicines Act 1981
New Zealand's Medicines Act 1981 defines a medical device broadly as any instrument, apparatus, appliance, material, or article intended for use in human diagnosis, prevention, monitoring, treatment, alleviation of disease, injury, handicap, investigation, replacement, modification of anatomy or physiological process, or control of conception, excluding certain exempted items and software with specific exclusions.
Approximately 5 minutes
Regulatory Requirements for Medical Devices in New Zealand
Under New Zealand's Medicines Act 1981 and related regulations, medical devices must comply with essential principles of safety and performance, undergo conformity assessment, meet labelling and advertising standards, and be notified to the WAND database before supply, with specific obligations for sponsors, importers, and manufacturers to ensure ongoing compliance and adverse event reporting.
Approximately 5 minutes
Risk Classification Rules for Medical Devices in New Zealand
New Zealand classifies non-IVD medical devices into four risk-based classes (I, IIa, IIb, III) and IVD devices into four classes (1–4) according to rules aligned with the EU system, considering intended purpose, duration of use, invasiveness, and potential harm to determine the appropriate level of regulatory scrutiny and conformity assessment.
Approximately 5 minutes
Contraceptive Devices Regulatory Requirements in New Zealand
Contraceptive devices in New Zealand are classified as high-risk medical devices (generally Class III or IIb) under the Medicines Act 1981, requiring stringent conformity assessment, WAND notification, and compliance with essential safety principles, with additional restrictions on advertising claims to the public to prevent misleading information about efficacy and safety.